Stay updated on Subcutaneous Durvalumab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Durvalumab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Durvalumab in Lung Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The history now shows a newer revision (v3.5.5) replacing the previous revision (v3.5.4), indicating that the record was updated.
    Difference
    0.1%
    Check dated 2026-06-05T21:38:40.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page's revision tag changed from v3.5.3 to v3.5.4. This indicates a minor update to the ClinicalTrials.gov interface with no impact on trial data or listings.
    Difference
    0.1%
    Check dated 2026-05-15T14:08:09.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page’s displayed software/version identifier was incremented from “v3.5.2” to “v3.5.3,” indicating a minor site update without altering the trial record information.
    Difference
    0.2%
    Check dated 2026-04-24T05:50:16.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page history shows a new site revision (v3.5.2) replacing the previous revision (v3.5.0).
    Difference
    0.1%
    Check dated 2026-04-17T02:33:22.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.3 to v3.5.0; no changes to study data or page content.
    Difference
    0.1%
    Check dated 2026-03-19T06:07:21.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 to the history and removed Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T02:55:03.000Z thumbnail image

Stay in the know with updates to Subcutaneous Durvalumab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Durvalumab in Lung Cancer Clinical Trial page.